相关实验视频
Updated: Jun 26, 2025

08:56
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
2.6K
[状周围神经病变和肌肉病变:一个诊断和治疗的挑战]
1Theodor Kocher Institute, University of Bern.
Brain and nerve = Shinkei kenkyu no shinpo
|May 14, 2024
概括
沙丘病可以影响神经和肌肉,导致外围神经病变和肌肉病变. 诊断需要排除其他疾病,虽然有治疗方法,但它们往往会抵抗治疗,因此需要进一步研究有效的选择.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- Sarcoidosis 是一种异常性粒状多器官疾病.
- 它通常会影响呼吸系统,眼睛和皮肤.
- 周围神经系统和肌肉的参与,虽然不太常见,可以发生.
研究的目的:
- 总结一下我们目前对类外围神经病变和肌肉病变的理解.
- 讨论诊断标准和当前的治疗策略.
- 突出管理方面的挑战和未来的研究方向.
主要方法:
- 关于类外围神经病变和肌肉病变的文献综述.
- 对诊断方法的分析,包括活检和排除标准.
- 治疗干预措施的概述,包括皮质类固醇,免疫抑制剂和生物药物.
主要成果:
- 状外围神经病变涉及骨和脊髓神经损伤.
- 肌肉参与呈现为成像或三种症状类型的无症状发现:结节性,急性和慢性肌肉病变.
- 诊断依赖于识别非病变性颗粒瘤,并排除其他病理.
- 目前的治疗包括皮质类固醇和免疫抑制剂,并越来越多地使用TNF-α抑制剂.
- 这些疾病往往表现出耐治疗性,需要长时间的治疗.
- 对表现特异性治疗的研究有限,并且没有建立标准协议.
结论:
- Sarcoid神经病变和肌肉病变是 Sarcoidosis 的罕见表现,需要仔细诊断.
- 由于治疗耐药性和缺乏既定标准,管理具有挑战性.
- 需要进一步的研究来开发有针对性和有效的疗法.
更多相关视频
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
9.3K
08:33Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
8.2K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
791
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
791
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K